More from Dividend.com
Referenced Stocks

Merck Still a “Buy” at UBS after New Osteoporosis Drug Proves Useful in Clinical Trial (MRK)

By Dividend.com,  July 13, 2012, 08:49:28 AM EDT

Pharmaceuticals maker Merck & Co., Inc. ( MRK ) on Friday received some bullish commentary from analysts at UBS.

The firm maintained its "Buy" rating and $45 price target on MRK, suggesting just a 5% upside to the stock's Thursday closing price of $42.91. UBS noted that the company's new osteoporosis drug, dubbed Odanacatib, has shown promise in recently trials.

Merck shares, which have risen nearly 14% year-to-date, were mostly flat in premarket trading Friday.

The Bottom Line
Shares of Merck ( MRK ) have a 3.92% dividend yield, based on last night's closing stock price of $42.91. The stock has technical support in the $38-$39 price area. If the shares can firm up, we see overhead resistance around the $45-$47 price levels.

Merck & Co., Inc. ( MRK ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Stocks

Referenced Stocks: MRK



Latest News Video

New Breast Cancer Drug Showing Promising Results
New Breast Cancer Drug Showing Prom...
Afghan Interpreters to Get UK Visas
Afghan Interpreters to Get UK Visas
South Africa's Growing Prosperity
South Africa's Growing Prosperity   
Translogic#119_517599791.Mp4
Translogic#119_517599791.Mp4        


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.44 0.07  0.52%
F $ 14.95 0.10  0.66%
CLWR $ 3.40 0.14  4.29%
SIRI $ 3.515 0.02  0.43%
MSFT $ 34.85 0.23  0.66%
CSCO $ 24.01 0.07  0.27%
MRK $ 47.33 2.12  4.69%
PFE $ 28.78 0.08  0.28%